Epigral, an integrated chemical manufacturer based in India, saw its share price increase by 15% to reach an intraday high of ₹1,400 on the National Stock Exchange (NSE) following the announcement of its highest-ever quarterly revenue of ₹736 crore for Q4FY26. This marks a 17.29% increase in net sales compared to the same quarter last year. Despite this revenue growth, the company's net profit fell by 6.84% to ₹80.95 crore, raising concerns about profitability. The company attributed its revenue growth to strong demand and improved utilization levels post-maintenance, while also noting challenges from the extended monsoon season. The board has proposed a final dividend of ₹5 per share, reflecting a 50% payout on the face value of ₹10. Furthermore, Epigral is progressing with its capital expenditure plans, which include significant expansions in CPVC resin and epichlorohydrin capacities, as well as increasing its wind-solar hybrid power plant capacity.